Table 3.
Associations between pulmonary hypertension and right ventricular dysfunction (pulmonary artery systolic pressure ≥ 40 mm Hg and/or more than moderate right ventricular dilatation) and baseline human immunodeficiency virus–hepatitis C virus characteristics, adjusted for age and sex
| Variable | OR | 95% CI | P Value |
|---|---|---|---|
| Any drug use | 0.47 | 0.06–3.81 | 0.481 |
| Injection drug use (current or past) | 0.45 | 0.04–4.74 | 0.509 |
| Time since HIV diagnosis, yr | 0.97 | 0.88–1.06 | 0.520 |
| CD4+ cell count | 0.45 | 0.03–6.95 | 0.565 |
| HIV viral load detectable | 0.97 | 0.20–4.66 | 0.969 |
| ART | 2.05 | 0.20–20.63 | 0.543 |
| Time since HCV diagnosis, yr | 1.21 | 0.97–1.50 | 0.097 |
| HCV viral load detectable | 1.07 | 0.23–5.04 | 0.936 |
| HCV treated | 5.65 | 1.06–29.93 | 0.042 |
| IFN treatment | 5.65 | 1.07–29.93 | 0.042 |
| Ribavirin treatment | 3.73 | 0.70–19.90 | 0.123 |
Definition of abbreviations: ART = antiretroviral therapy; CI = confidence interval; HCV = hepatitis C virus; HIV = human immunodeficiency virus; IFN = interferon; OR = odds ratio.